ODDB.org: Open Drug Database | Médicaments

100 ml

3.98

13.55

10%

Reckitt Benckiser
(Switzerland) AG

B / LS / SG

Posaconazol Accord 40
mg/ml

105 ml

513.14

574.50

10%

Accord Healthcare AG

B / LS / SG

Atomoxetin-Mepha 10 mg

Capsules: Atomoxetinum 10 mg

10%

A / LS / SG

Atomoxetin-Mepha 18 mg

Capsules: Atomoxetinum 18 mg

10%

A / LS / SG

Atomoxetin-Mepha 18 mg

Capsules: Atomoxetinum 18 mg

10%

A / LS / SG

Atomoxetin-Mepha 25 mg

Capsules: Atomoxetinum 25 mg

10%

A / LS / SG

Atomoxetin-Mepha 25 mg

Capsules: Atomoxetinum 25 mg

10%

A / LS / SG

Atomoxetin-Mepha 40 mg

Capsules: Atomoxetinum 40 mg

10%

A / LS / SG

Atomoxetin-Mepha 40 mg

Capsules: Atomoxetinum 40 mg

10%

A / LS / SG

Atomoxetin-Mepha 60 mg

Capsules: Atomoxetinum 60 mg

10%

A / LS / SG

Capsules: Atomoxetinum 80 mg

Atomoxetin-Mepha 80 mg

41.59

61.00

10%

A / LS / SG

Capsules: Atomoxetinum 100 mg

Atomoxetin-Mepha 100 mg

41.59

61.00

10%

A / LS / SG

10%

Solution injectable: Pegfilgrastimum 6mg / 0.6ml

Medius AG

A / LS

10%

Solution injectable en seringue prête à l'emploi: Brolucizumabum 120 mg/ml

Novartis Pharma
Schweiz AG

B / LS

Solution injectable en seringue prête à l'emploi: Pegfilgrastimum 6mg / 0.6ml

Ziextenzo 6 mg / 0.6 ml

1001.72

1105.85

10%

Sandoz
Pharmaceuticals AG

A / LS

Concentré pour perfusion: Ravulizumabum 300mg / 30ml

Ultomiris 300 mg/30 ml

4035.23

4181.20

10%

Alexion Pharma GmbH

A / LS

Concentré pour perfusion: Ravulizumabum 300mg / 3ml

Ultomiris 300 mg/3 ml

4035.23

4181.20

10%

Alexion Pharma GmbH

A / LS

Concentré pour perfusion: Ravulizumabum 1100mg / 11ml

Ultomiris 1100 mg/11 ml

14795.84

15221.60

10%

Alexion Pharma GmbH

A / LS

10%

Comprimés retards: Upadacitinibum 15 mg

AbbVie AG

B / LS

Comprimés retards: Upadacitinibum 30 mg

Rinvoq 30 mg

765.24

848.65

10%

AbbVie AG

B / LS

Comprimés retards: Upadacitinibum 45 mg

Rinvoq 45 mg

1744.75

1913.95

10%

AbbVie AG

B / LS

56 g

10%

gel: Diclofenacum Natricum 20 mg

Gebro Pharma AG

D / LS

112 g

10%

gel: Diclofenacum Natricum 20 mg

Gebro Pharma AG

D / LS

V/S

1 +

10%

Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml

Takeda Pharma AG

B / LS

V/S

1 +

10%

Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml

Takeda Pharma AG

B / LS

V/S

1 +

10%

Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml

Takeda Pharma AG

B / LS

V/S

1 +

10%

Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml

Takeda Pharma AG

B / LS

V/S

1 +

10%

Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml

Takeda Pharma AG

B / LS

Solution injectable: Burosumabum 10 mg/ml

Crysvita 10 mg/1 ml

N.O.

Kyowa Kirin Sàrl

Solution injectable: Burosumabum 20 mg/ml

Crysvita 20 mg/1 ml

N.O.

Kyowa Kirin Sàrl

Solution injectable: Burosumabum 30 mg/ml

Crysvita 30 mg/1 ml

N.O.

Kyowa Kirin Sàrl

Similasan Reise-
Beschwerden N

N.O.

Comprimés: 4 Principes actifs

Similasan AG

30 ml

N.O.

Reckitt Benckiser
(Switzerland) AG

50 ml

N.O.

Reckitt Benckiser
(Switzerland) AG

150 ml

N.O.

Reckitt Benckiser
(Switzerland) AG

Solution injectable en seringue prête à l'emploi: Pegfilgrastimum 6mg / 0.6ml

Ziextenzo 6 mg / 0.6 ml

26378.16

27283.60

N.O.

Sandoz
Pharmaceuticals AG

Rüedi Xylo PLUS
Nasenspray

10 ml

N.O.

Solution: 2 Principes actifs

Spirig HealthCare AG